Skip to main content
Log in

Improved Bone Health Behavior Using Community Pharmacists as Educators

The Geisinger Health System Community Pharmacist Osteoporosis Education Program

  • Original Research Article
  • Published:
Disease Management and Health Outcomes

Abstract

Background: Osteoporosis is an exceedingly common, morbid, and potentially fatal disease. Efforts to improve the prevention, diagnosis and treatment of osteoporosis in people living in Central Pennsylvania were instituted in 1996 by the Geisinger Health System. With a catchment of over 2 million people, over 600 physicians and 50 primary care sites, this physician-led system of healthcare is uniquely positioned to influence the delivery of healthcare.

Objective: To determine whether the pilot Community Pharmacist Osteoporosis Education Program, a specific project of the osteoporosis disease management program by the Geisinger Health System, improved bone health behavior.

Methods: The Community Pharmacist Osteoporosis Education Program, focused on physician and allied healthcare provider guidelines, community intervention, bone density testing, and outcomes analysis, can improve bone health. A group of highly motivated community-based pharmacists were educated about menopause and osteoporosis prevention, diagnosis, and treatment. They were provided with a uniform educational program and held classes in the community. Baseline, satisfaction, and follow-up questionnaires were administered. High risk participants received a follow-up telephone encounter. Primary care physicians were notified about the program and their patients’ participation.

Results: Approximately 350 women attended the classes. The mean age was 54 years, 99.4% were Caucasian, and 47% had some education beyond high school. One-third had a family history of osteoporosis or fracture. Participants were uniformly satisfied with the course content and class delivery: 74% rated the class as ‘excellent’, 26% as ‘good’. Follow-up questionnaires at 4 to 6 months demonstrated that of those who were not previously doing so, 58% began taking calcium supplements, 32% exercised more, 50% sought the counsel of their primary care physician, 29% obtained a test of bone density, and 33% started a prescription medication for osteoporosis therapy as a result of attending the class. High risk participants were more likely to obtain a test of bone density after the program than were low risk participants.

Conclusion: This program demonstrates that community-based pharmacists can serve as a valuable member of the healthcare provider team. An organized program that provides a standard and consistent educational approach, physician communication, and a reminder system led to better bone health behavior in women in the community.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1

Similar content being viewed by others

References

  1. Ross PD. Osteoporosis: frequency, consequences, and risk factors. Arch Intern Med 1996; 156: 1399–411

    Article  PubMed  CAS  Google Scholar 

  2. Lindsay R, Christiansen C, Einhorn TA, et al. Consensus development statement: who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 1997; 7: 1–6

    Article  Google Scholar 

  3. National Osteoporosis Foundation. 1996 and 2015 osteoporosis prevalence figures — state by state report. Washington, DC: National Osteoporosis Foundation, 1997 Jan: 1–11

    Google Scholar 

  4. Newman ED, Starkey RS, Ayoub WT, et al. Osteoporosis disease management: best practices from the Penn State Geisinger Health System. J Clin Outcomes Manage 2000 May; 7(5): 23–8

    Google Scholar 

  5. Newman ED, Ayoub W, Hanus P, et al. Osteoporosis clinical practice guideline. 2nd ed. Danville (PA): Geisinger Health System, 2000 Apr: 1–24

    Google Scholar 

  6. Lydick E, Cook K, Turpin J, et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 1998; 4: 37–48

    PubMed  CAS  Google Scholar 

  7. European Foundation for Osteoporosis and the National Osteoporosis Foundation. Consensus development statement. Who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 1997; 7: 1–6

    Google Scholar 

  8. American Association of Health Plans. Health plans’innovative programs in mid-life women’s health issues: advancing women’s health. Washington, DC: American Association of Health Plans, 1998

    Google Scholar 

  9. American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in primary care. Am J Health Syst Pharm 1999 Aug; 56: 1665–7

    Google Scholar 

  10. Holdford D, Kennedy DT, Bernadella P, et al. Implementing disease management in community pharmacy practice. Clin Ther 1998 Mar–Apr; 20(2): 328–39

    Article  PubMed  CAS  Google Scholar 

  11. Baran RW, Crumlish K, Patterson H, et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm 1999 Aug; 56: 1535–9

    PubMed  CAS  Google Scholar 

  12. Liu MY, Jennings JP, Samuelson WM, et al. Asthma patients’ satisfaction with the frequency and content of pharmacy counseling. J Am Pharm Assoc 1999 Jul–Aug; 39(4): 493–8

    CAS  Google Scholar 

  13. Woolf AD, Delmas PD. How can we reduce the burden of osteoporosis? Bailliere’s Clin Rheumatol 1997 Aug; 11(3): 451–7

    Article  CAS  Google Scholar 

  14. Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. J Clin Endocrinol Metab 2000; 85(11): 4118–24

    Article  PubMed  CAS  Google Scholar 

  15. Miller P, Roux C, McClung M, et al. Risedronate reduces hip fracture in patients with low femoral neck bone mineral density. Arthritis Rheum 1999 Sep; 9 Suppl.: S287

    Google Scholar 

  16. O’Neill T, Papapoulos S. Can we prevent fractures? Bailliere’s Clin Rheumatol 1997 Aug; 11(3): 565–82

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge the Wilkes University School of Pharmacy for their support of the pharmacist educational training, Merck & Co., Inc. for their assistance in program design, and Design-a-Care Advisory Group for their assistance in facilitating program implementation. This program was supported in part by unrestricted educational grants from Merck & Co., Inc., Wyeth-Ayerst Laboratories, and Novartis Pharmaceuticals.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric D. Newman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Newman, E.D., Hanus, P. Improved Bone Health Behavior Using Community Pharmacists as Educators. Dis-Manage-Health-Outcomes 9, 329–335 (2001). https://doi.org/10.2165/00115677-200109060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200109060-00004

Keywords

Navigation